CONSOLIDATED STATEMENTS OF COMMON SHAREHOLDERS' EQUITY (USD $) In Millions, except Share data, unless otherwise specified		Total	Common Stock [Member]		Additional Paid-in Capital [Member]	Unearned ESOP Compensation [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Retained Earnings [Member]	Total common Shareholders' Equity [Member]	Noncontrolling Interest [Member]	FPL [Member]	FPL [Member] Common Stock [Member]	FPL [Member] Additional Paid-in Capital [Member]	FPL [Member] Retained Earnings [Member]
BEGINNING BALANCE at Dec. 31, 2011											$ 10,850	$ 1,373	$ 5,464	$ 4,013
Beginning Balance at Dec. 31, 2011		14,943	4		5,270	(53)	(154)	9,876	14,943	0
Balances (in shares) at Dec. 31, 2011			416,000,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		1,911						1,911	1,911
NET INCOME		1,911									1,240			1,240
Issuances of common stock, net of issuance cost of less than $1					367.0	4.0			371.0
Issuances of common stock, net of issuance cost (in shares)			6,000,000
Repurchases of common stock					(19)				(19)
Repurchases of common stock (in shares)			0
Exercise of stock options and other incentive plan activity					98				98
Exercise of stock options and other incentive plan activity (in shares)			2,000,000
Dividends on common stock	[1]							(1,004)	(1,004)
Earned compensation under ESOP					34	10			44
Other comprehensive income (loss)		(101)					(101)		(101)
Premium on equity units					(151)				(151)
Issuance costs on equity units					(24)				(24)
Capital contributions from NEE											440		440
Other													(1)	1
Ending Balance at Dec. 31, 2012		16,068	4		5,575	(39)	(255)	10,783	16,068	0
ENDING BALANCE at Dec. 31, 2012											12,530	1,373	5,903	5,254
Balance (in shares) at Dec. 31, 2012	[2]		424,000,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	[3],[4],[5],[6]	272
NET INCOME	[3],[5]										288
Ending Balance at Mar. 31, 2013
BEGINNING BALANCE at Dec. 31, 2012											12,530	1,373	5,903	5,254
Beginning Balance at Dec. 31, 2012		16,068	4		5,575	(39)	(255)	10,783	16,068	0
Balances (in shares) at Dec. 31, 2012	[2]		424,000,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		1,908						1,908	1,908
NET INCOME		1,908									1,349			1,349
Issuances of common stock, net of issuance cost of less than $1					823.0	4.0			827.0
Issuances of common stock, net of issuance cost (in shares)			10,000,000
Exercise of stock options and other incentive plan activity					74				74
Exercise of stock options and other incentive plan activity (in shares)			1,000,000
Dividends on common stock	[1]							(1,122)	(1,122)
Earned compensation under ESOP					37	9			46
Other comprehensive income (loss)		311					311		311
Premium on equity units					(62)				(62)
Issuance costs on equity units					(10)				(10)
Capital contributions from NEE											275		275
Other													1	(1)
Dividends to NEE														(1,070)
Ending Balance at Dec. 31, 2013		18,040	4		6,437	(26)	56	11,569	18,040
ENDING BALANCE at Dec. 31, 2013		18,040									13,084	1,373	6,179	5,532
Balance (in shares) at Dec. 31, 2013		435,000,000	435,000,000	[2]							1,000
BEGINNING BALANCE at Sep. 30, 2013
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	[3],[5]	327
NET INCOME	[3],[5]										248
Ending Balance at Dec. 31, 2013		18,040
ENDING BALANCE at Dec. 31, 2013		18,040									13,084	1,373
Balance (in shares) at Dec. 31, 2013		435,000,000									1,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	[3],[5]	430
NET INCOME	[3],[5]	430									347
Ending Balance at Mar. 31, 2014
BEGINNING BALANCE at Dec. 31, 2013		18,040									13,084	1,373	6,179	5,532
Beginning Balance at Dec. 31, 2013		18,040	4		6,437	(26)	56	11,569	18,040	0
Balances (in shares) at Dec. 31, 2013		435,000,000	435,000,000	[2]							1,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		2,469						2,465	2,465	4
NET INCOME		2,465									1,517			1,517
Issuances of common stock, net of issuance cost of less than $1					604.0	3.0			607.0
Issuances of common stock, net of issuance cost (in shares)			7,000,000
Exercise of stock options and other incentive plan activity					102				102
Exercise of stock options and other incentive plan activity (in shares)			1,000,000
Dividends on common stock	[1]							(1,261)	(1,261)
Earned compensation under ESOP					50	9			59
Other comprehensive income (loss)		(98)					(96)		(96)	(2)
NEP acquisition of limited partnership interest in NEP OpCo										232
Capital contributions from NEE											100		100
Other										18
Dividends to NEE														(1,550)
Ending Balance at Dec. 31, 2014		20,168	4		7,193	(14)	(40)	12,773	19,916	252
ENDING BALANCE at Dec. 31, 2014		19,916									13,151	1,373	6,279	5,499
Balance (in shares) at Dec. 31, 2014		443,000,000	443,000,000	[2]							1,000
BEGINNING BALANCE at Sep. 30, 2014
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	[3],[5]	884
NET INCOME	[3],[5]	884									286
Ending Balance at Dec. 31, 2014		20,168
ENDING BALANCE at Dec. 31, 2014		$ 19,916									$ 13,151	$ 1,373
Balance (in shares) at Dec. 31, 2014		443,000,000									1,000

[1] Dividends per share were $2.90, $2.64 and $2.40 for the years ended December 31, 2014, 2013 and 2012, respectively.

[2] Outstanding and unallocated shares held by the Employee Stock Ownership Plan (ESOP) Trust totaled approximately 1 million, 2 million and 3 million at December 31, 2014, 2013 and 2012, respectively; the original number of shares purchased and held by the ESOP Trust was approximately 25 million shares.

[3] In the opinion of NEE and FPL, all adjustments, which consist of normal recurring accruals necessary to present a fair statement of the amounts shown for such periods, have been made. Results of operations for an interim period generally will not give a true indication of results for the year.

[4] First quarter of 2013 includes an after-tax gain from discontinued operations. See Note 6.

[5] The sum of the quarterly amounts may not equal the total for the year due to rounding.

[6] First quarter of 2013 includes impairment and other related charges. See Note 4 - Nonrecurring Fair Value Measurements.